Regulatory Update

Arlington, Va. – September 17, 2026 -- Bloomberg Tax & Accounting has projected a 3.2% inflation increase for 2027, up from the 2.7% rise recorded for 2026, according to its newly released 2027 Projected U.S. Tax Rates report.

Bureau of Labor Statistics data gap forces 11-month calculation method

The Bureau of Labor Statistics failed to report October 2025 data, an unprecedented lapse that required Bloomberg Tax to compute the Chained Consumer Price Index for All Urban Consumers (C-CPI-U) using an 11-month average instead of the standard 12-month period.

Washington – September 17, 2026 -- The Transportation Security Administration marked the 25th anniversary of the September 17, 2026 attacks by launching its Horizon 25 Strategy, a modernization push covering all transportation modes under the Trump administration and Secretary Mullin.

TSA traces its origin to the Aviation and Transportation Security Act signed into law on September 17, 2026

President George W. Bush created the agency in direct response to the attacks that killed nearly 3,000 people, tasking it with restoring confidence in the aviation system and safeguarding freedom of movement for people and commerce.

Administrator David P. Cummins says the agency must modernize against sophisticated, evolving threats

"TSA must modernize to defend against those threats," Cummins said, framing Horizon 25 as the vehicle to advance capabilities across all modes of transportation and ensure a September 11 attack "never happens again."

Plymouth, Mich. – – September 17, 2026 -- Esperovax, Inc. has secured a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application No. 18/038,673, covering its engineered yeast platform for producing therapeutic proteins directly inside the body.

USPTO clears patent covering in vivo yeast-based protein expression

The allowed application, titled "Yeast-Based Expression of Therapeutic Proteins In Vivo," protects technology that uses engineered yeast administered to patients to manufacture biologic proteins within the body itself, rather than requiring external production and repeated dosing of purified biologics.

Cincinnati – September 17, 2026 -- Government inspectors found overcharging at more than one in three Kroger stores examined across nine Ohio jurisdictions, according to a report released this week by the Center for Responsible Food Business (CRFB). Pricing errors favored Kroger nearly three times as often as they favored shoppers.

Inspection records show 58 of 389 store checks failed between 2022 and mid-2026

The public-records data, covering nine Ohio jurisdictions, documented 644 incorrect prices during 389 inspections. Overcharges averaged more than 20 percent above posted shelf prices, and 36 of 101 stores examined were caught overcharging at least once.

Stockholm – September 17, 2026 -- Husqvarna Group has become the first robotics company to secure Conditional Approval from the U.S. Federal Communications Commission (FCC) for foreign-manufactured advanced robotic devices, clearing a key regulatory hurdle for its U.S. expansion.

FCC exempts four Husqvarna mower platforms from national security covered list

The FCC's Public Safety and Homeland Security Bureau announced the approval on September 17, 2026, covering four Automower platforms: the 305V iQ, 310V iQ, 420V iQ and 440V iQ. The decision follows the FCC's August 2026 publication of a covered list identifying communications equipment deemed a national security risk; the Conditional Approval exempts these specific Husqvarna platforms, along with models already sold in the U.S., from that list.

Dallas – September 17, 2026 -- Toby R. Neugebauer, together with Vicksburg Investments Management LLC and the Melissa A. Neugebauer 2020 Trust, has filed a formal SEC Rule 14a-8 shareholder proposal demanding Fermi Inc. (Nasdaq: FRMI) retain an independent, nationally recognized investment bank to review the full range of extraordinary transactions available to the company, including a full-value sale or majority recapitalization. The Fermi Founder Parties, who hold approximately 22% of shares outstanding, submitted the proposal September 10 ahead of the company's October 30 Annual Meeting, following a letter to the Board on September 9 and a detailed presentation on September 10.

Washington – September 17, 2026 -- Seventeen Volunteer Advocates from the American Foundation for Suicide Prevention (AFSP) will meet with members of Congress from September 16-18 to push for sustained federal funding and pending legislation on suicide prevention, arriving weeks after Congress passed the Youth Poisoning Protection Act (H.R. 1442/S. 289), which now awaits presidential signature.

Advocates from 14 states demand $549.6 million for the 988 Suicide & Crisis Lifeline

The delegation, sponsored for a second year by AFSP's Illinois chapter during National Suicide Prevention Month, is lobbying for robust funding of the 988 Lifeline at $549.6 million, a $38 million allocation for the CDC's Comprehensive Suicide Prevention Program (CSP), and $2.548 billion for the National Institute of Mental Health.

Clayton, Mo. and The Woodlands, Texas – – September 17, 2026 -- Olin Corporation (NYSE: OLN) and Huntsman Corporation (NYSE: HUN) confirmed that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired, clearing a key regulatory hurdle for their planned merger of equals.

HSR clearance removes a major closing condition for the chemical sector merger

The expiration satisfies one of the primary conditions required to close the transaction, though the deal still awaits additional regulatory approvals that are currently underway.

Shareholders of both companies approved the deal on September 17, 2026

Investors from Olin and Huntsman overwhelmingly backed the merger of equals at their respective shareholder votes, clearing the corporate governance path toward completion.

Valby, Denmark – – September 17, 2026 -- The U.S. Food and Drug Administration has granted Orphan Drug Designation to asedebart (Lu AG13909), Lundbeck's investigational anti-ACTH monoclonal antibody, for the treatment of endogenous Cushing's syndrome.

FDA designation adds U.S. market exclusivity potential for Lundbeck's rare disease pipeline

The designation covers drugs and biologics intended for rare diseases and can provide tax credits for qualified clinical testing, exemption from certain FDA application fees, and up to seven years of market exclusivity if the drug is approved for the designated indication.

Los Angeles – September 17, 2026 -- DJS Law Group has reminded shareholders of a class action lawsuit filed against EquipmentShare.com Inc. (NASDAQ: EQPT), alleging the company violated federal securities law by concealing related-party transactions from investors.

Class Period Covers January 23 to September 17, 2026

The lawsuit, brought under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5, covers investors who purchased EquipmentShare stock between September 17, 2026 and September 17, 2026. Shareholders who suffered losses on trades within this window may be eligible to join the litigation.